Psoriasis is a chronic, inflammatory, multisystem disease which affects up to 3.2% of the U.S population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine (AM) will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults
Objective. To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatm...
Psoriasis is a common, chronic inflammatory skin disease affecting many people of the world now a da...
International audienceThese guidelines were developed by the psoriasis research group of the French ...
Psoriasis is a chronic, inflammatory, multisystem disease which affects up to 3.2% of the U.S popula...
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US populati...
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US populatio...
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approxima...
AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly ...
The purpose of these Guidelines is to summarize the most relevant features of the pathogenesis, clin...
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children,...
Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythema...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that af...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that ...
Psoriasis is a chronic disease that has a substantial effect on quality of life of patients and ofte...
Psoriasis is a complex disease with a spectrum of clinical manifestations. Psoriasis may express as ...
Objective. To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatm...
Psoriasis is a common, chronic inflammatory skin disease affecting many people of the world now a da...
International audienceThese guidelines were developed by the psoriasis research group of the French ...
Psoriasis is a chronic, inflammatory, multisystem disease which affects up to 3.2% of the U.S popula...
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US populati...
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US populatio...
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approxima...
AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly ...
The purpose of these Guidelines is to summarize the most relevant features of the pathogenesis, clin...
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children,...
Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythema...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that af...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that ...
Psoriasis is a chronic disease that has a substantial effect on quality of life of patients and ofte...
Psoriasis is a complex disease with a spectrum of clinical manifestations. Psoriasis may express as ...
Objective. To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatm...
Psoriasis is a common, chronic inflammatory skin disease affecting many people of the world now a da...
International audienceThese guidelines were developed by the psoriasis research group of the French ...